FOCUS Investment Banking Represents Forgentum, Inc. In its Acquisition by Fulcrum IT Services
Washington, DC (February 28, 2014) – FOCUS Investment Banking, a ...
FOCUS Investment Banking Represents Medvance Ltd. in Acquisition by NAMSA FOCUS closes another international deal in the healthcare industry
Washington, DC (January 7, 2014) FOCUS, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced that its client, Medvance Ltd., has been acquired by NAMSA. FOCUS represented Medvance in the transaction, adding another international deal to its list of completed 2013 transactions.
Alzheimer’s Disease and the Growing Dementia Epidemic
Most of us know someone—relative, friend, or colleague—suffering from dementia, a medical term that describes symptoms of impaired cognition (memory and thinking), behavior, social abilities, and daily functioning. Dementia isn’t a specific disease and can range in severity from mild to severe. It has many different non-reversible and reversible causes.
Middle Market Investment Banking Firm, FOCUS LLC, Represents Pleiad in Acquisition by CROMSOURCE International Transaction in Life Sciences and Clinical Research Organization Industry
Washington, DC (June 4, 2012) – FOCUS LLC, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced that Pleiad, domiciled in Stirling,Scotland, with a substantial presence in the U.S. (Cambridge, Massachusetts) has been acquired by CROMSOURCE, headquartered in Verona, Italy. FOCUS represented Pleiad in the transaction.
Middle Market Investment Banking Firm FOCUS LLC Represents PositiveID Corporation in Acquisition of MicroFluidic Systems, a Leader in Biological Testing and Sample Prep Applications. Acquisition Reinforces Trend of Increased M&A Activity in the Healthcare and Life Sciences Industry.
Washington DC (June 3, 2011) – FOCUS LLC, a national ...
Middle Market Investment Banking Firm FOCUS LLC Represents the Bioline Group of Companies in its Sale to Meridian Bioscience, Inc. Deal Marks Tenth Deal for FOCUS in 2010
Washington DC (July 23, 2010) – FOCUS LLC, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that the Bioline group of companies has been acquired by Meridian Bioscience, Inc. (NASDAQ: VIVO). FOCUS represented Bioline in this transaction.
Middle Market Investment Banking Firm FOCUS LLC Represents Verify Solutions in Acquisition by HMS Holdings Acquisition of Healthcare Audit Company Marks 12th Deal for FOCUS in 2009
Verify Solutions in Acquisition Acquired by ...
FOCUS LLC Secures Financing for Agentek, Inc.
Washington, DC and Atlanta, GA (April 3, 2008) – FOCUS ...
FOCUS Enterprises, Inc. announces the purchase of Benefits Marketing Solutions by Alliance HealthCard, a public company headquartered in Atlanta.
Benefits Marketing Solutions by Alliance HealthCard ...